Publication | Closed Access

Drug–Drug Interaction Potential of Marketed Oncology Drugs: In Vitro Assessment of Time-Dependent Cytochrome P450 Inhibition, Reactive Metabolite Formation and Drug–Drug Interaction Prediction

Drug InteractionsMarketed Oncology DrugsPreclinical Drug EvaluationPharmacological StudyMedicineDrug–drug Interaction PredictionToxicologyDrug–drug Interaction PotentialPharmacodynamic ModelingPharmacologyRadiation OncologyPharmacokineticsDrug Discovery